Correlation Engine 2.0
Clear Search sequence regions


  • d (3)
  • diagnosis (1)
  • dioxygenases (1)
  • glutarates (2)
  • humans (1)
  • inhibit (1)
  • reagents (1)
  • Sizes of these terms reflect their relevance to your search.

    Gain-of-function mutations of isocitrate dehydrogenase 1 and 2 (IDH1/2) were demonstrated to induce the production and accumulation of oncometabolite 2-hydroxyglutarate (2HG). 2HG is a potent competitor of α-ketoglutarate (α-KG) and can inhibit multiple α-KG-dependent dioxygenases that are critical for regulating the metabolic and epigenetic state of cells. The accumulation of 2HG contributes to elevated risk of malignant tumors. 2HG carries an asymmetric carbon atom in its carbon backbone and therefore occurs in two enantiomers, D-2-hydroxyglutarate (D-2HG) and L-2-hydroxyglutarate (L-2HG). Each enantiomer is produced and metabolized in independent biochemical pathway and catalyzed by different enzymes. The accurate diagnosis of 2HG-related diseases relies on determining the configuration of the two enantiomers. Quantitative methods for analysis of D-2HG and L-2HG have been well developed. These analytical strategies mainly include the use of chiral chromatography medium to facilitate chromatographic separation of enantiomers prior to spectroscopy or mass spectrometry analysis and the use of chiral derivatization reagents to convert the enantiomers to diastereomers with differential physical and chemical properties that can improve their chromatographic separation. Here, we summarize and discuss these established methods for analysis of total 2HG as well as the determination of the enantiomers of D-2HG and L-2HG.

    Citation

    Bi-Feng Yuan. Quantitative Analysis of Oncometabolite 2-Hydroxyglutarate. Advances in experimental medicine and biology. 2021;1280:161-172

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33791981

    View Full Text